Experience

Hammersmith Medicines Research Ltd

• United Kingdom
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Associate Director of Clinical Science

  • Nov 2021 - Present

• Head of Clinical Science

  • Dec 2020 - Oct 2022

• Deputy Head of Clinical Sciences

  • Sep 2013 - Dec 2020



University of Oxford

• United Kingdom
• Research Services
• 700 & Above Employee

• Postdoctoral Researcher

  • Dec 2011 - Sep 2013



Barts and the London School of Medicine and Dentistry

• Research Services
• 100 - 200 Employee

• Research assistant (Post-Doc)

  • Apr 2011 - Nov 2011

  Collaboration between Centre for Neuroscience and Trauma, Queen Mary University of London, and Vifor Pharma, Switzerland Project title: Exploration of the neuroprotective effects of EQUAZEN Senior in vitro and ex vivo Collaboration between Centre for Neuroscience and Trauma, Queen Mary University of London, and Vifor Pharma, Switzerland Project title: Exploration of the neuroprotective effects of EQUAZEN Senior in vitro and ex vivo



Barts and the London School of Medicine and Dentistry

• Research Services
• 100 - 200 Employee

• Research Assistant

  • Oct 2010 - Feb 2011

  Project title: Studies on the effects of the omega-3 PUFA eicosapentaenoic acid and docosahexaenoic acid in the G93A SOD1 mouse, an animal model of ALS Project title: Studies on the effects of the omega-3 PUFA eicosapentaenoic acid and docosahexaenoic acid in the G93A SOD1 mouse, an animal model of ALS



Centre for Neuroscience and Trauma, Barts and The London

• PhD Student

  • Oct 2007 - Oct 2010

  Project title: Neuroprotective and regenerative effects of omega-3 PUFAs on primary sensory neurons in vivo and in vitro Project title: Neuroprotective and regenerative effects of omega-3 PUFAs on primary sensory neurons in vivo and in vitro